Bukola Adebesin, Kelley Weinfurtner, Alexander Zavriyev, Molly Sheehan, Stephen Kadlecek, David Tischfield, Terence P. Gade Multimodal 18F-FDG PET and Hyperpolarized [1-13C] Pyruvate Magnetic Resonance Spectroscopy for Subtype-Specific Treatment Response Prediction in Hepatocellular Carcinoma , World Molecular Imaging Congress Annual Meeting: 2026
Isabella Farkas, Kelley Weinfurtner, Kim Olthoff, Peter Abt, Fady Kaldas, Mark Rosen, Gentian Lluri, Jack Rychik, Maarouf Hoteit, Yuli Kim Incidental Hepatocellular Carcinoma on Explant Pathology in Patients With Fontan Circulation After Combined Heart-Liver Transplantation , JACC Case Reports: 2026
Boehmler D, Baron R, Crainic J, Islam A, Kim Y, Gurevich A, Perkons N, Zavriyev A, Amin R, Andrew-Udoh J, Tuzneen Supan E, El Ghazal R, Hunt SJ, McClung G, Tischfield D, Ackerman D, Weljie A, Weinfurtner K, Skuli N, Gade TPF. Locoregional Lactate Dehydrogenase Inhibition Potentiates
Therapy and Overcomes Treatment Resistance in
Hepatocellular Carcinoma , Hepatology: 2026
Weinfurtner K, Amin R, Skuli N, Gade TPF, Kaplan DE Patient-derived models of liver cancer to inform therapeutic decision: recent updates , Seminars in Liver Disease, 46: 2026,51-62
Yan L, Huang L, Wright C, Gade TPF, Weinfurtner K Intra-patient tumor-level outcomes of transarterial chemoembolization versus transarterial radioembolization for multifocal hepatocellular carcinoma , Society of Interventional Oncology Annual Meeting: 2026
Bukola Y. Adebesin Multiparametric Hyperpolarized-13C-MRI for Sensitive Assessment of Early-Stage Liver Disease , AASLD Annual Liver Meeting: 2026
Kim Y, McClung G, Wright C, Tischfield D, Furth EE, Kaffe E, Weinfurtner K, Gade TPF Hepatocyte Humanization in an SRG Rat Model After Partial Hepatectomy , AASLD The Liver Meeting : 2025
Hoteit MA, Abt PL, Priore SF, Tondon R, Abu-Gazala A, Agarwal P, Weinfurtner K, Hilscher MB, Wangensteeen KJ Molecular patterns associated with recurrence and survival in intrahepatic cholangiocarcinoma (iCCA) / hepatocholangiocarcinoma (HCC-CCA) after liver transplantation , AASLD The Liver Meeting: 2025
Ferrante ND, Hubbard RA, Weinfurtner K, Mezina AI, Newcomb CW, Furth EE, Bhattacharya D, Njei B, Taddei, TH, Singal A, Hoteit MA, Park LS, Kaplan DE, Lo Re V. Validity of Diagnostic Codes and Laboratory Tests to Identify Cholangiocarcinoma and Its Subtypes , Pharmacoepidemiol Drug Saf, 34(5): 2025,e70154
Hoteit M, Weinfurtner K Recurrent hepatocellular carcinoma after liver transplantation: Small steps, while awaiting a breakthrough. , Liver Transplantation: 2025
